MyD88 inhibition downregulates the downstream RANKL e and prevents periodontitis-induced bone loss, indicating that RANKL within osteocytes is a critical therapeutic target for inflammatory osteolysis during peri-implantitis (121). This evidence concerns the gene TNFSF11 and Peri-Implantitis.